Safety of macitentan for the treatment of pulmonary hypertension: Real‐world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)

Macitentan is an oral endothelin receptor antagonist for the management of pulmonary arterial hypertension (PAH). The OPsumit® USers Registry (OPUS) and the OPsumit® Historical USers cohort (OrPHeUS) medical chart review provide real‐world data for patients newly initiating macitentan. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Vallerie V., Channick, Richard, Kim, Nick H., Frantz, Robert P., McConnell, John W., Melendres‐Groves, Lana, Miller, Chad, Ravichandran, Ashwin, Rodriguez‐Lopez, Josanna, Brand, Monika, Leroy, Sandrine, Wetherill, Graham, Chin, Kelly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661363/
https://www.ncbi.nlm.nih.gov/pubmed/36381290
http://dx.doi.org/10.1002/pul2.12150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661363/
https://www.ncbi.nlm.nih.gov/pubmed/36381290
http://dx.doi.org/10.1002/pul2.12150

Ejemplares similares